355 related articles for article (PubMed ID: 34951921)
1. New developments in ankylosing spondylitis-status in 2021.
Klavdianou K; Tsiami S; Baraliakos X
Rheumatology (Oxford); 2021 Dec; 60(Suppl 6):vi29-vi37. PubMed ID: 34951921
[TBL] [Abstract][Full Text] [Related]
2. Management of Axial Spondyloarthritis - Insights into Upadacitinib.
Braun J; Kiltz U; Baraliakos X
Drug Des Devel Ther; 2022; 16():3609-3620. PubMed ID: 36268520
[TBL] [Abstract][Full Text] [Related]
3. Treatment of axial spondyloarthritis: an update.
Danve A; Deodhar A
Nat Rev Rheumatol; 2022 Apr; 18(4):205-216. PubMed ID: 35273385
[TBL] [Abstract][Full Text] [Related]
4. The Future of Axial Spondyloathritis Treatment.
Maguire S; Sengupta R; O'Shea F
Rheum Dis Clin North Am; 2020 May; 46(2):357-365. PubMed ID: 32340707
[TBL] [Abstract][Full Text] [Related]
5. The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials.
Denis A; Sztejkowski C; Arnaud L; Becker G; Felten R
RMD Open; 2023 Jul; 9(3):. PubMed ID: 37507210
[TBL] [Abstract][Full Text] [Related]
6. Current Unmet Needs in Spondyloarthritis.
Poddubnyy D; Sieper J
Curr Rheumatol Rep; 2019 Jul; 21(9):43. PubMed ID: 31302784
[TBL] [Abstract][Full Text] [Related]
7. Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis.
Braun J; Kiltz U; Baraliakos X
Expert Opin Biol Ther; 2023 Feb; 23(2):195-206. PubMed ID: 36511882
[TBL] [Abstract][Full Text] [Related]
8. No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors.
Zhang H; Jiang HL; Dai SM
Front Immunol; 2022; 13():818413. PubMed ID: 35222393
[TBL] [Abstract][Full Text] [Related]
9. Targeting the interleukin-23/17 axis in axial spondyloarthritis.
Paine A; Ritchlin CT
Curr Opin Rheumatol; 2016 Jul; 28(4):359-67. PubMed ID: 27152702
[TBL] [Abstract][Full Text] [Related]
10. The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis.
Sieper J; Poddubnyy D; Miossec P
Nat Rev Rheumatol; 2019 Dec; 15(12):747-757. PubMed ID: 31551538
[TBL] [Abstract][Full Text] [Related]
11. Emerging drugs for the treatment of axial spondyloarthritis.
Rademacher J; Poddubnyy D
Expert Opin Emerg Drugs; 2018 Mar; 23(1):83-96. PubMed ID: 29475394
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological management of axial spondyloarthritis in adults.
Toussirot E
Expert Opin Pharmacother; 2019 Aug; 20(12):1483-1491. PubMed ID: 31095430
[No Abstract] [Full Text] [Related]
13. New evidence on the management of spondyloarthritis.
Sieper J; Poddubnyy D
Nat Rev Rheumatol; 2016 May; 12(5):282-95. PubMed ID: 27052489
[TBL] [Abstract][Full Text] [Related]
14. Janus Kinase Inhibitors: A New Tool for the Treatment of Axial Spondyloarthritis.
Paroli M; Caccavale R; Paroli MP; Spadea L; Accapezzato D
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674537
[TBL] [Abstract][Full Text] [Related]
15. Axial spondyloarthritis.
Navarro-Compán V; Sepriano A; El-Zorkany B; van der Heijde D
Ann Rheum Dis; 2021 Dec; 80(12):1511-1521. PubMed ID: 34615639
[TBL] [Abstract][Full Text] [Related]
16. New treatment targets for axial spondyloarthritis.
Sieper J
Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii38-ii42. PubMed ID: 27856659
[TBL] [Abstract][Full Text] [Related]
17. Emerging treatment options for spondyloarthritis.
Torgutalp M; Poddubnyy D
Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):472-484. PubMed ID: 31171316
[TBL] [Abstract][Full Text] [Related]
18. Secukinumab: a promising therapeutic option in spondyloarthritis.
Maldonado-Ficco H; Perez-Alamino R; Maldonado-Cocco JA
Clin Rheumatol; 2016 Sep; 35(9):2151-61. PubMed ID: 27437696
[TBL] [Abstract][Full Text] [Related]
19. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.
Wallman JK; Kapetanovic MC; Petersson IF; Geborek P; Kristensen LE
Arthritis Res Ther; 2015 Dec; 17():378. PubMed ID: 26703005
[TBL] [Abstract][Full Text] [Related]
20. Developments with experimental and investigational drugs for axial spondyloarthritis.
Clavel G; Boissier MC; Sigaux J; Semerano L
Expert Opin Investig Drugs; 2017 Jul; 26(7):833-842. PubMed ID: 28562100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
